Assessment of nephroprotective potential of Sida cordifolia Linn. in experimental animals

Der Pharmacia Lettre

Volumn 4, Issue 1, 2012, Pages 175-180

  Makwana, Mehul V ^a,b   Pandya, Nilesh M ^a   Darji, Dharmesh N ^b   Desai, Sarav A ^b   Bhaskar, V H ^c  

^a Singhania University   (India)

^b Pioneer Pharmacy Degree College   (India)

^c MP Patel College of Pharmacy   (India)

Author keywords

Cisplatin; Gentamicin; Nephrotoxicity; Sida cordifolia Linn.

Indexed keywords

CISPLATIN; CREATININE; GENTAMICIN; SIDA CORDIFOLIA EXTRACT; UREA; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE URINE LEVEL; DRUG POTENCY; DRUG SAFETY; FEMALE; KIDNEY INJURY; LD 50; MALE; MALVACEAE; NEPHROTOXICITY; NONHUMAN; PLANT ROOT; RAT; RENAL PROTECTION; SIDA CORDIFOLIA; TOXICITY TESTING; UREA BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL;

EID: 84867735853     PISSN: None     EISSN: 09755071     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Halliwell B, Gutteridge JM, Cross CE. J Lab Clin Med 1992; 119:598-620.
2. Awkins CL, Brown BE, Davies MJ. Arch Biochem Biophys 2001; 395(2):137-45.
3. McCord JM. Am J Med 2000; 108:652-9.
4. Maldonadu PD, Barrera D, Rivero I, Mata R, Copos ON, Pando RH. Bio med 2003; 35:317- 24.
5. Silan C, Uzuno O, Comunoglu NU. Biol Pharm Bull 2007; 30(1):79-89.
6. Yaman I, Balikci E. Exp Toxicol Pathol 2010;62(2):183-90.
7. Reiter RJ, Tan D, Sainz RM, Mayo JC, Lopez-Burillo S. J Pharm Pharmacol 2002; 54:1299- 1321.
8. Kirtikar KR and Basu BD. Indian medicinal plants; 428 - 29.
9. Franzotti EM, Santos CV, Rodrigues HM, Mourao RH, Andrade MR, Antoniolli R. J Ethnopharmacol 2000; 72 (1-2): 273 - 77.
10. Kumar SR, Mishra SH. Indian drugs 1997; 34 (12): 702-06.
11. Auddy B, Ferreira M, Blasina F, Lafon L, Arredondo F, Dajas F et al. J Ethnopharmacol 2003; 84 (2 - 3): 131 - 38.
12. rd march 2006. [cited 2008 Jun 20]; Available from:URL:www.oecd.org
13. Karahan I, Atessahin A, Yilmaz S, Ceribasi AO, Sakin F. Toxicology 2005; 215: 198-204.
14. Harilaka GV, Patil CR, Patil MR. Indian J Pharmacol 2007; 39(4): 201-05.
15. Noori S, Mahboob T. Indian J Clin Biochem 2010; 25(1): 86-91.
16. Badary OA, Abdel-maksoud S, Ahmed WA, Owieda GH. Life sciences 2005; 76: 2125-35.
17. Abdel-Naim, AB, Abdel-Wahab, MH, Attia, FF. Pharmacol. Res. 1999; 40 (2), 183-187.
18. Baliga R, Ueda N, Walker PD, Shah SV. Drug Metab. Rev. 1999; 31 (4), 971-997.
19. Eisenberg JM, Koffer H, Glick HA, Connell ML, Loss LE, Talbot GH, Shusterman NH, Strom BL. Ann. Intern. Med. 1987; 107 (6), 900-909.
20. Wiland P, Szechcinski J. Pol. J. Pharmacol.2003; 55, 631-637.
21. Badary OA, Nagi MN, Al-Sawaf HA, Al-Harbi M, Al-Bekairi AM. Nephron 1997; 77 (4), 435-439.
22. DeConti RC, Toftness BR, Lange RC, Creasey WA. Cancer Research 1987; 33 (6), 1310- 1315.
23. Heidemann HT, Muller S, Mertins L, Stepan G, Hoffmann K, Ohnhaus EE. British Journal of Pharmacology 1989; 97 (2), 313-318.
24. McKeage MJ, Morgan SE, Boxall FE, Murrer BA, Hard GC, Harrap KR. British Journal of Cancer 1993; 67 (5), 996-1000.